Cargando…
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
BACKGROUND: Protein tyrosine phosphatase receptor type D (PTPRD) is a putative tumor suppressor in several cancers including head and neck squamous cell carcinoma (HNSCC). STAT3 is a frequently hyperactivated oncogene in HNSCC. As STAT3 is a direct substrate of PTPRD, we sought to determine the gene...
Autores principales: | Peyser, Noah D., Du, Yu, Li, Hua, Lui, Vivian, Xiao, Xiao, Chan, Timothy A., Grandis, Jennifer R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534317/ https://www.ncbi.nlm.nih.gov/pubmed/26267899 http://dx.doi.org/10.1371/journal.pone.0135750 |
Ejemplares similares
-
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016) -
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015) -
Critical analysis of the potential for targeting STAT3 in human malignancy
por: Peyser, Noah D, et al.
Publicado: (2013) -
JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth()()
por: Sen, Malabika, et al.
Publicado: (2015) -
SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
por: Zhou, Z, et al.
Publicado: (2016)